Page 113 - 73_01

VOL. 73 (1), 47-64, 2007 REGULACIÓN EPIGENÉTICA EN LA PANCREATITIS NECRÓTICA AGUDA

(15) STEWART, M. D.; LI, J. and WONG, J. (2005): Relationship between histone H3
(16) lysine 9 methylation, transcription repression, and heterochromatin protein
(17) 1 recruitment. Mol. Cell. Biol. 25: 2525-2538.
(18) SILVERSTEIN, R. A. and EKWALL, K. (2005): Sin3: a flexible regulator of global
(19) gene expression and genome stability. Curr. Genet. 47: 1-17.
(20) CAO, X.; MAHENDRAN, R.; GUY, G. R. and TAN, Y. H. (1993): Detection and
(21) characterization of cellular EGR-1 binding to its recognition site. J. Biol.
(22) Chem. 268: 16949-16957.
(23) KACHIGIAN, L. M.; WILLIAMS, A. J. and COLLINS, T. (1995): Interplay of Sp1 and
(24) Egr-1 in the proximal platelet-derived growth factor A-chain promoter in
(25) cultured vascular endothelial cells. J. Biol. Chem. 270: 27679-27686.
LI, D. H.; HAVELL, E. A.; BROWN, C. L. and CULLEN, J. M. (2000): Woodchuck
(26) lymphotoxin-alpha, -beta and tumor necrosis factor genes: structure, charac-
(27) terization and biological activity. Gene. 242: 295-305.
CHEN, C. C.; LEE, W. R. and SAFE, S. (2004b): Egr-1 is activated by 17beta-
(28) estradiol in MCF-7 cells by mitogen-activated protein kinase-dependent phos-
(29) phorylation of ELK-1. J. Cell. Biochem. 93: 1063-1074.
(30) THOTTASSERY, J. V.; SUN, D.; ZAMBETTI, G. P.; TROUTMAN, A.; SUKHATME, V. P.;
SCHUETZ, E. G. and SCHUETZ, J. D. (1999): Sp1 and egr-1 have opposing effects
on the regulation of the rat Pgp2/mdr1b gene. J. Biol. Chem. 274: 3199-3206.
KACHIGIAN, L. M.; WILLIAMS, A. J. and COLLINS, T. (1995): Interplay of Sp1 and
Egr-1 in the proximal platelet-derived growth factor A-chain promoter in
cultured vascular endothelial cells. J. Biol. Chem. 270: 27679-27686.
VASSALLI, P. (1992): The pathophysiology of tumor necrosis factors. Annu.
Rev. Immunol. 10: 411-452.
WARD, A. and CLISSOLD, S. P. (1987): Pentoxifylline. A review of its pharma-
codynamic and pharmacokinetic properties, and its therapeutic efficacy.
Drugs. 34: 50-97.
PEREDA, J.; SABATER, L.; CASSINELLO, N., GÓMEZ-CAMBRONERO, L.; CLOSA, D.; FOL-
CH-PUY, E.; APARISI, L.; CALVETE, J., CERDA, M.; LLEDO, S.; VINA, J. and SASTRE,
J. (2004): Effect of simultaneous inhibition of TNF-alpha production and
xanthine oxidase in experimental acute pancreatitis: the role of mitogen ac-
tivated protein kinases. Ann. Surg. 240: 108-116.
EDWARDS, M. J.; ABNEY, D. L. and MILLER, F. N. (1991): Pentoxifylline inhibits
interleukin-2-induced leukocyte-endothelial adherence and reduces systemic
toxicity. Surgery. 110: 199-204.
SCHANDENE, L.; VANDENBUSSCHE, P.; CRUSIAUX, A.; ALEGRE, M. L.; ABRAMOWICZ, D.;
DUPONT, E., CONTENT, J. and GOLDMAN, M. (1992): Differential effects of pen-
toxifylline on the production of tumour necrosis factor-alpha (TNF-alpha)
and interleukin-6 (IL-6) by monocytes and T cells. Immunology. 76: 30-34.
BHATIA, M.; WONG, F. L.; CAO, Y.; LAU, H. Y.; HUANG, J.; PUNEET, P. and CHEVALI,
L. (2005): Pathophysiology of acute pancreatitis. Pancreatology. 5: 132-144.
KUSSKE, A. M.; RONGIONE, A. J. and REBER, H. A. (1996): Cytokines and acute
pancreatitis. Gastroenterology. 110: 639-642.
KINGSNORTH, A. (1997): Role of cytokines and their inhibitors in acute pan-
creatitis. Gut. 40: 1-4.

63